HNF4α is a crucial modulator of the cholesterol-dependent regulation of NPC1L1

被引:53
作者
Iwayanagi, Yuki [1 ]
Takada, Tappei [1 ]
Suzuki, Hiroshi [1 ]
机构
[1] Univ Tokyo, Fac Med, Tokyo Univ Hosp, Dept Pharm,Bunkyo Ku, Tokyo 1138655, Japan
关键词
cholesterol; HNF4; alpha; intestinal transport; NPC1L1; transcriptional regulation;
D O I
10.1007/s11095-007-9496-9
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. Niemann-Pick C1-like 1 (NPC1L1) has been identified as a target of ezetimibe and found to be responsible for intestinal cholesterol absorption. Although, it was recently demonstrated that sterol responsive element binding protein 2 (SREBP2) is responsible for the cholesterol-dependent down-regulation of NPC1L1, the molecular mechanism of NPC1L1 expression is not fully understood. In the present study, we examined the involvement of hepatocyte nuclear factor 4 alpha (HNF4 alpha), a key modulator of lipid metabolism, in the transcriptional regulation of human NPC1L1 gene. Methods. Reporter gene assays and EMSAs were performed using human NPC1L1 promoter constructs and the effect of siHNF4 alpha was examined. Results. Transfection of SREBP2 induced the transcriptional activities of NPC1L1 and additional transfection of HNF4 alpha results in a marked stimulation of the activities. Studies with deletion mutants indicated that important elements are located within 264 nt upstream in the human NPC1L1 promoter. In addition, studies with mutations in putative binding sites of HNF4 alpha indicated the existence of binding sites in -209 to -197 and -52 to -40. Moreover, HNF4 alpha knockdown resulted in the reduced expression and regulation by cholesterol. Conclusions. It is concluded that HNF4 alpha plays a crucial role in the expression and regulation of human NPC1L1 gene.
引用
收藏
页码:1134 / 1141
页数:8
相关论文
共 50 条
  • [21] NPC1L1: Evolution from pharmacological target to physiological sterol transporter
    Huff, Murray W.
    Pollex, Rebecca L.
    Hegele, Robert A.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (11) : 2433 - 2438
  • [22] Inactivating Mutations in NPC1L1 and Protection from Coronary Heart Disease
    Stitziel, Nathan O.
    Won, Hong-Hee
    Morrison, Alanna C.
    Peloso, Gina M.
    Do, Ron
    Lange, Leslie A.
    Fontanillas, Pierre
    Gupta, Namrata
    Duga, Stefano
    Goel, Anuj
    Farrall, Martin
    Saleheen, Danish
    Ferrario, Paola
    Koenig, Inke
    Asselta, Rosanna
    Merlini, Piera A.
    Marziliano, Nicola
    Notarangelo, Maria Francesca
    Schick, Ursula
    Auer, Paul
    Assimes, Themistocles L.
    Reilly, Muredach
    Wilensky, Robert
    Rader, Daniel J.
    Hovingh, G. Kees
    Meitinger, Thomas
    Kessler, Thorsten
    Kastrati, Adnan
    Laugwitz, Karl-Ludwig
    Siscovick, David
    Rotter, Jerome I.
    Hazen, Stanley L.
    Tracy, Russell
    Cresci, Sharon
    Spertus, John
    Jackson, Rebecca
    Schwartz, Stephen M.
    Natarajan, Pradeep
    Crosby, Jacy
    Muzny, Donna
    Ballantyne, Christie
    Rich, Stephen S.
    O'Donnell, Christopher J.
    Abecasis, Goncalo
    Sunyaev, Shamil
    Nickerson, Deborah A.
    Buring, Julie E.
    Ridker, Paul M.
    Chasman, Daniel I.
    Austin, Erin
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (22) : 2072 - 2082
  • [23] Inhibition of hepatocyte nuclear factor 1 and 4 alpha (HNF1α and HNF4α) as a mechanism of arsenic carcinogenesis
    Pastoret, Anna
    Marcos, Ricard
    Sampayo-Reyes, Adriana
    Saucedo-Cardenas, Odila
    Lozano-Garza, Gerardo H.
    Hernandez, Alba
    ARCHIVES OF TOXICOLOGY, 2013, 87 (06) : 1001 - 1012
  • [24] Dietary diosgenin transcriptionally down-regulated intestinal NPC1L1 expression to prevent cholesterol gallstone formation in mice
    Shen, Weiyi
    Shao, Wentao
    Wang, Qihan
    Wang, Bo
    Zhao, Gang
    Gu, Aihua
    Jiang, Zhaoyan
    Hu, Hai
    JOURNAL OF BIOMEDICAL SCIENCE, 2023, 30 (01)
  • [25] Intestinal CREBH overexpression prevents high-cholesterol diet-induced hypercholesterolemia by reducing Npc1l1 expression
    Kikuchi, Takuya
    Orihara, Kana
    Oikawa, Fusaka
    Han, Song-iee
    Kuba, Motoko
    Okuda, Kanako
    Satoh, Aoi
    Osaki, Yoshinori
    Takeuchi, Yoshinori
    Aita, Yuichi
    Matsuzaka, Takashi
    Iwasaki, Hitoshi
    Yatoh, Shigeru
    Sekiya, Motohiro
    Yahagi, Naoya
    Suzuki, Hiroaki
    Sone, Hirohito
    Nakagawa, Yoshimi
    Yamada, Nobuhiro
    Shimano, Hitoshi
    MOLECULAR METABOLISM, 2016, 5 (11): : 1092 - 1102
  • [26] Characterization of the NPC1L1 gene and proteome from an exceptional responder to ezetimibe
    Schweitzer, Morris
    Makhoul, Sandra
    Paliouras, Miltiadis
    Beitel, Lenore K.
    Gottlieb, Bruce
    Trifiro, Mark
    Chowdhury, Shafinaz F.
    Zaman, Naif M.
    Wang, Edwin
    Davis, Harry
    Chalifour, Lorraine E.
    ATHEROSCLEROSIS, 2016, 246 : 78 - 86
  • [27] Dietary diosgenin transcriptionally down-regulated intestinal NPC1L1 expression to prevent cholesterol gallstone formation in mice
    Weiyi Shen
    Wentao Shao
    Qihan Wang
    Bo Wang
    Gang Zhao
    Aihua Gu
    Zhaoyan Jiang
    Hai Hu
    Journal of Biomedical Science, 30
  • [28] The target of ezetimibe is Niemann-Pick Cl-Like 1 (NPC1L1)
    Garcia-Calvo, M
    Lisnock, JM
    Bull, HG
    Hawes, BE
    Burnett, DA
    Braun, MP
    Crona, JH
    Davis, HR
    Dean, DC
    Detmers, PA
    Graziano, MP
    Hughes, M
    MacIntyre, DE
    Ogawa, A
    O'Neill, KA
    Iyer, SPN
    Shevell, DE
    Smith, MM
    Tang, YS
    Makarewicz, AM
    Ujjainwalla, F
    Altmann, SW
    Chapman, KT
    Thornberry, NA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (23) : 8132 - 8137
  • [29] NPC1L1 knockout protects against colitis-associated tumorigenesis in mice
    Jianming He
    Hyunsu Shin
    Xing Wei
    Anil Kumar G Kadegowda
    Rui Chen
    Sandy Krystal Xie
    BMC Cancer, 15
  • [30] NPC1L1 knockout protects against colitis-associated tumorigenesis in mice
    He, Jianming
    Shin, Hyunsu
    Wei, Xing
    Kadegowda, Anil Kumar G.
    Chen, Rui
    Xie, Sandy Krystal
    BMC CANCER, 2015, 15